Cell & Gene Therapies

CAR‑T, CRISPR, in vivo delivery, manufacturing, and long‑term follow‑up.

  • 4 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Cell & Gene Therapies


bioengineer.org > dual-t-cell-activator-breathes-new-life-into-checkpoint-therapy-for-resistant-cancers

Dual T-Cell Activator Breathes New Life Into Checkpoint Therapy for

26+ min ago   (75+ words) Immune checkpoint inhibitors have transformed the treatment landscape for many cancers, yet a stubborn fraction of patients either never respond or relapse after an initial benefit. The central obstacle in these refractory cases is T-cell exhaustion: tumor-fighting CD8+ T cells that…...


bioengineer.org > deadly-wheat-fungus-reveals-a-hidden-molecular-switch-that-controls-its-toxin-and-spread

Deadly Wheat Fungus Reveals a Hidden Molecular Switch That Controls Its

45+ min ago   (96+ words) Scientists have uncovered a previously hidden partnership inside one of the world’s most destructive crop pathogens, and the discovery could reshape how farmers fight a disease that devastates wheat harvests and poisons grain supplies. A research team working on Fusarium…...


bioengineer.org > second-car-t-cell-infusion-hits-myeloma-after-celmod-bridging

Second CAR T-Cell Infusion Hits Myeloma After CELMoD Bridging

1+ hour, 26+ min ago   (475+ words) A case report from German hematologists suggests that patients with advanced multiple myeloma may still benefit from a second BCMA-directed CAR T-cell therapy, even after their disease has progressed following a first such treatment....


openpr.com > news > 4636057 > car-t-clinical-trial-pipeline-gains-momentum-180-companies

CAR-T Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

2+ day, 12+ hour ago   (60+ words) CAR-T Clinical Trial Pipeline Gains Momentum: 180+ Companies openPR.com CAR-T Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight Press release from: ABNewswire Permanent link to this press release: You can edit or delete your…...


insideprecisionmedicine.com > topics > oncology > crispr-activation-tool-uncovers-genes-linked-to-lymphoma-drug-resistance

CRISPR Activation Tool Uncovers Genes Linked to Lymphoma Drug Resistance

2+ day, 11+ hour ago   (505+ words) Inside Precision Medicine A new whole-genome CRISPR screening platform has helped researchers identify a previously unknown gene causing lymphoma cells to become resistant to a widely used cancer drug, as well as several genes that can accelerate tumor growth. Published…...


eurekalert.org > news-releases > 1143775

Gene that drives blood cancer drug resistance uncovered with new CRISPR activation tool

2+ day, 11+ hour ago   (437+ words) Researchers used a powerful new guide RNA library, Partita, to find genes that help lymphoma cells escape treatment and accelerate tumor growth image: L-R: Dr Eddie La Marca, Prof Marco Herold; L-R: Dr Yexuan Deng, Dr Margaret Potts, Dr Sarah…...


miragenews.com > crispr-tool-unveils-gene-behind-blood-cancer-1747136

CRISPR Tool Unveils Gene Behind Blood Cancer Drug Resistance

2+ day, 11+ hour ago   (338+ words) GLOBAL: Researchers have uncovered a previously unknown gene causing resistance to a leading blood cancer drug and several genes that accelerate lymphoma growth by using a powerful new CRISPR activation library. Traditional CRISPR is a genetic engineering tool that allows…...


news-medical.net-medical.net

iPSC-derived CAR γδ T cells for liver cancer

2+ day, 18+ hour ago   (374+ words) Autologous chimeric antigen receptor (CAR) T cell therapies are now a part of standard treatment protocol for hematological malignancies. Despite this, they are deeply constrained by elevated costs and delayed access for patients. Allogeneic donor-derived CAR T cells make off-the-shelf…...


newsnetwork.mayoclinic.org > discussion > study-shows-reprogramming-thyroid-tumors-may-improve-car-t-cell-therapy

Study shows reprogramming thyroid tumors may improve CAR-T cell therapy

2+ day, 18+ hour ago   (592+ words) ROCHESTER, Minn. — Mayo Clinic researchers have identified a strategy that could help chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, overcome a major barrier to treating solid tumors: Cancer cells can change in ways that allow them to hide…...